Celebrating Diversity Within the Sickle Cell Community: Commitment, Innovation, Practice
avatar for Lori Luck, MD

Lori Luck, MD

PFIZER Inc, Collegeville Pennsylvania Global Medical Affairs, Sickle Cell Disease
Medical Director
Lori Luck, M.D. is a pediatric hematologist and joined Pfizer in January, 2017 as the Medical Director, Global Medical Affairs, Sickle Cell Disease. Prior to Pfizer, Dr. Luck worked in Oncology at Genzyme and Leadiant (formally Sigma Tau) in Field Medical Affairs. She completed her pediatric residency at Children’s Hospital of Michigan and pediatric hematology-oncology fellowship at Children’s Hospital Los Angeles. Dr. Luck credits her mentors, Sharada Sarnaik, MD and Punam Malik, MD, for her intense desire to improve the lives of individuals living with sickle cell disease and, under their tutelage, had been awarded the Sheldon Brenner Resident Research Award and Post-Doctoral Fellowship Award, bestowed by the Sickle Cell Disease Association of America, Inc. After fellowship, Dr. Luck moved to Philadelphia, Pennsylvania and joined the Marian Anderson Comprehensive Sickle Cell Center at St. Christopher’s Hospital for Children (SCHC) to work under the directorship of Carlton Dampier, MD. During her five-year tenure at SCHC, Dr. Luck had acted as local Principal Investigator for the Baby HUG study. Dr. Luck realizes the broad impact that can be achieved through her work in Global Medical Affairs at Pfizer, however, she admits to missing the rewarding interactions with her beloved “little patients”.